Company Update Bajaj Healthcare Ltd - 539872 - Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015 BSE India The Company has received recommendation from SEC (Neurology & Psychiatry) of CDSCO to conduct Phase III clinical trials for Cenobamate Tablets